COVID-19 Clinical Research Studies

COVID-19 clinical research examines how SARS-CoV-2 infects human cells—primarily through the ACE2 receptor—spreads through populations, and drives the immune and physiological responses that determine patient outcomes. A central concern has been understanding why the virus triggers disproportionately severe complications in some individuals, including cytokine storm, widespread thrombosis, and multi-organ dysfunction, while causing mild or no symptoms in others. Researchers are working to clarify the long-term effects of infection, refine antiviral and immunomodulatory treatments, and identify the host and viral factors that explain this variability. Open questions remain around the durability of immunity, the mechanisms underlying post-acute sequelae, and how viral evolution affects both disease severity and therapeutic efficacy.

Works

106,422

Total citations

2,216,217

Keywords

Clinical CharacteristicsSARS-CoV-2EpidemiologyThrombosisImmune ResponseACE2 Receptor